A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
NCT00189501
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Nephrology
Interventions
DRUG:
Sensipar®
Sponsor
Amgen